Abstract
This paper presents the architecture of the electronic detection and data processing (analysis) part, of a Lab-on- Chip (LoC) device. The data processing part focuses on the analysis of signals captured from the sensors used to detect possible mutations in the sample under consideration. The LoC consists of a micro-fluidics part for the sample preparation and hybridization, a micro-system part including the sensors for the hybridization electronic detection and finally a processing part for the data analysis and an interface for results presentation. The use of such LoCs aims at identifying the appropriate cluster of patients for a pharmacogenomic medicine based on the gene analysis results and at optimizing the effectiveness of the drug or determining whether the affected patient belongs to a group of patients who would suffer severe side effects.
Keywords: Lab-on-chip, embedded system, multi-core SoC, microarray, sensor signal processing, pharmacogenomics
Micro and Nanosystems
Title: Lab-on-Chip for Pharmacogenomics: An Embedded System Organization
Volume: 1 Issue: 1
Author(s): George Kornaros, Athanasios Demiris and Spyros Blionas
Affiliation:
Keywords: Lab-on-chip, embedded system, multi-core SoC, microarray, sensor signal processing, pharmacogenomics
Abstract: This paper presents the architecture of the electronic detection and data processing (analysis) part, of a Lab-on- Chip (LoC) device. The data processing part focuses on the analysis of signals captured from the sensors used to detect possible mutations in the sample under consideration. The LoC consists of a micro-fluidics part for the sample preparation and hybridization, a micro-system part including the sensors for the hybridization electronic detection and finally a processing part for the data analysis and an interface for results presentation. The use of such LoCs aims at identifying the appropriate cluster of patients for a pharmacogenomic medicine based on the gene analysis results and at optimizing the effectiveness of the drug or determining whether the affected patient belongs to a group of patients who would suffer severe side effects.
Export Options
About this article
Cite this article as:
Kornaros George, Demiris Athanasios and Blionas Spyros, Lab-on-Chip for Pharmacogenomics: An Embedded System Organization, Micro and Nanosystems 2009; 1 (1) . https://dx.doi.org/10.2174/1876402910901010030
DOI https://dx.doi.org/10.2174/1876402910901010030 |
Print ISSN 1876-4029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-4037 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
In-vitro Evaluation of Transungual Formulation of Ketoconazole for the Management of Onychomycosis
Drug Delivery Letters The Effects of Drugs Used in Anaesthesia on Platelet Membrane Receptors and on Platelet Function
Current Drug Targets Genetic Transmission of Cytochrome P450 2D6 (CYP2D6) Ultrarapid Metabolism: Implications for Breastfeeding Women taking Codeine
Current Drug Safety The Effects of Omega-3 Supplementation on the Expanded Disability Status Scale and Inflammatory Cytokines in Multiple Sclerosis Patients: A Systematic Review and Meta-Analysis
CNS & Neurological Disorders - Drug Targets Editorial [Hot Topic: Clinical Relevance of Indoleamine 2,3-Dioxygenase (Guest Editor: Dietmar Fuchs) ]
Current Drug Metabolism Insulin-Degrading Enzyme: Structure-Function Relationship and its Possible Roles in Health and Disease
Current Pharmaceutical Design Mesenchymal Stromal Cell Secretome: Immunomodulation, Tissue Repair and Effects on Neurodegenerative Conditions
Current Stem Cell Research & Therapy Strategies for Stalling Malignancy: Targeting Cancers Addiction to Hsp90
Current Topics in Medicinal Chemistry Internal Jugular Vein Valve Morphology in the Patients with Chronic Cerebrospinal Venous Insufficiency (CCSVI); Angiographic Findings and Schematic Demonstrations
Reviews on Recent Clinical Trials Synthetic LXR Agonist Suppresses Endogenous Cholesterol Biosynthesis and Efficiently Lowers Plasma Cholesterol
Current Pharmaceutical Biotechnology Appraisal of AβPP Transgenic Mice as Models for Alzheimers Disease Amyloid Cascade
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Perspective in Medicinal Chemistry
Current Topics in Medicinal Chemistry The ABCA2 Transporter: Intracellular Roles in Trafficking and Metabolism of LDL-Derived Cholesterol and Sterol-Related Compounds
Current Drug Metabolism Neuropeptides as Therapeutic Approach to Autoimmune Diseases
Current Pharmaceutical Design The Role of Therapeutic Drugs on Acquired Mitochondrial Toxicity
Current Drug Metabolism Rational Combination of Targeted Therapies As A Strategy to Overcome The Mechanisms of Resistance to Inhibitors of EGFR Signaling
Current Pharmaceutical Design Multiple Sclerosis - A Coordinated Immune Attack Across the Blood Brain Barrier
Current Neurovascular Research Protective Effects of the Caffeine Against Neurodegenerative Diseases
Current Medicinal Chemistry Neurologic and Cardiovascular Complications in Pediatric Life Threatening Imipramine Poisoning
Current Drug Safety Assessment of Cytochrome P450 Enzyme Inhibition and Inactivation in Drug Discovery and Development
Current Topics in Medicinal Chemistry